Zhongshan Ophthalmic Center
Guangzhou, Guangdong, 510060, China
NCT Number: NCT02423382
The purpose of this study is to evaluate the effects of long-term tamponade with silicone oil on retinal saturation with Oxymap.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510060, China
Silicone oil is the first choice treatment for long-term vitreous replacement in complicated cases of retinal detachment. However, it will cause various problems for permanent tamponade, such as keratopathy, glaucoma, cataracts, and silicone oil emulsification3. In addition, silicone oil has the potential to cause retinal toxicity. Moreover, the gravity and mechanical pressure of the silicone oil on the retina may influence retinal blood flow and, and the presence of silicone oil in the vitreous cavity may block the oxygen exchange between the retinal surface and the vitreous humor, resulting in the metabolic disturbance of the retina. In this study, the investigators utilized a noninvasive measurement (Oxymap, Reykjavik, Iceland) to evaluate the effect of silicone oil tamponade on oxygen saturation and diameter in retinal vessels in complicated retinal detachment cases.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The patients in each group will receive the same procedure of silicone oil removal.
Time frame: 1 day before silicone oil removal and 2 months after silicone oil removal.
Time frame: 1 day before silicone oil removal and 2 months after silicone oil removal.
Sun Yat-sen University
Other
Measurement of the Retinal Oxygen Saturaiton After Long-term Silicon Oil Tamponade With Oxymap
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04676256
Eye Diseases, Retinal Break
Paris, Île-de-France Region, France
View Trial DetailsNCT01767038
Eye Diseases, Retinal Detachment
Besançon, France
View Trial DetailsNCT07058337
Eye Diseases, Retinal Detachment
Cairo, Egypt
View Trial DetailsNCT03479736
Achilles Tendon, Acute Aortic Syndrome
Titusville, New Jersey, United States
View Trial Details